Clinical Trials Directory

Trials / Conditions / Chronic Myeloid Leukaemia

Chronic Myeloid Leukaemia

12 registered clinical trials studyying Chronic Myeloid Leukaemia — 1 currently recruiting.

StatusTrialSponsorPhase
RecruitingCondition Vasoregulation Function Endothelium in Patients With CML Getting TKI II Generation Bosutinib
NCT05682924
Samara State Medical University—
CompletedReal-World Disease Management and Outcomes in Chronic Myeloid Leukaemia
NCT05893836
Novartis Pharmaceuticals—
CompletedStudy to Evaluate Chronic Myeloid Leukemia Treatment Landscape and Real-life Treatment Outcomes in Hungary: An
NCT05286528
Pfizer—
CompletedA Study To Describe The Real World Use Of Bosutinib In The UK And Netherlands
NCT02546375
Pfizer—
CompletedPegylated Interferon Alfa-2b and Nilotinib for Augmentation of Complete Molecular Response in Chronic Myeloid
NCT02001818
Australasian Leukaemia and Lymphoma GroupPhase 2
CompletedDe- Escalation and Stopping Treatment of Imatinib, Nilotinib or sprYcel in Chronic Myeloid Leukaemia
NCT01804985
University of LiverpoolPhase 2
CompletedFront-line Nilotinib Treatment of BCR-ABL+ Chronic Myeloid Leukaemia in Chronic Phase
NCT01699217
Gruppo Italiano Malattie EMatologiche dell'Adulto—
CompletedTrial of Haploidentical Stem Cell Transplantation for Haematological Cancers
NCT01597219
University College, LondonPhase 2
CompletedObservational Study in Adults With Imatinib-resistant/Intolerant Chronic Myeloid Leukemia Treated With Nilotin
NCT01475110
Gruppo Italiano Malattie EMatologiche dell'Adulto—
CompletedWT1 TCR Gene Therapy for Leukaemia: A Phase I/II Safety and Toxicity Study
NCT01621724
Cell Medica LtdPhase 1 / Phase 2
CompletedMulticenter Trial Estimating the Persistence of Molecular Remission in Chronic Myeloid Leukaemia in Long Term
NCT01343173
University Hospital, BordeauxN/A
CompletedGlivec® (Imatinib Mesylate, STI571) in Monotherapy Versus Glivec®-Interferon Alpha in the Treatment of Chronic
NCT00390897
PETHEMA FoundationPhase 4